🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Someone tell Olaf Scholz that if it's ok for Kremlin to donate heavy weapons to Ukraine, it's ok for Germany to as well.

#Germany's Defense Minister Lambrecht said that #Ukraine's recent battlefield gains won't alter Berlin's refusal to deliver tanks. What's wrong with you, Germany? Why do you play in the interests of #Russia? politico.eu/article/ukrain…

Germany’s policy on Ukraine is incomprehensible. The positions of FDP & SPD appear outright hostile and pro-Russian. Unwise and unethical. That will be very costly for Germany.

Ройзману Евгений Ройзман 60 сегодня. Все самые лучшие поздравления от меня! Достойный политик, народный любимец и просто хороший человек.

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals loom.ly/NzRyfsk

Congrats to our member Juliane for receiving the International #Immunocompromised Host Society Takeda #Virology #Award 2022 in the category "Best laboratory #science 2020-22" for the development of a #COVID19 #peptide #vaccine for the induction of #SARSCoV2 T cell #immunity.

Hint to my EU friends: Putin is getting money for oil and gas (and EU is the largest buyer) via traditional banking transfers, not via crypto. Russian opposition who fight Putin get money from supporters via crypto, not via traditional banking transfers. Please, do the math.

Please don't just watch us get killed online. It's not a show. It's our lives, millions of lives. Act! Please help us win. Help us stay alive. Give us combat planes and air defense systems. Delay is paid for in human lives.

It is a great honour to receive the second year in a row the DGHO e. V. Best Abstract #award for our work on developing a #COVID19 T cell activator for #Cancer #patients with B cell deficiency.

Congratulations to Juliane Walz on receiving the “Best Abstract” award! #DGHO2022 She reported on our #COVID19 vaccine candidate CoVac-1 for (cancer) patients with B cell deficiency at the DGHO e. V. Annual Meeting in Vienna. Peptide-based Immunotherapy

An oncogenic fusion protein as target for novel #immunotherapies of cancer. We are so excited to share our study, which identified the oncogenic fusion protein DNAJB1-PRKACA as source of #neoantigens for peptide-based immunotherapy in #FLHCC! nature.com/articles/s4146…

We are very excited to share our work published in Science Immunology showing that different #vaccination regimens induce broad and long-lasting spike-specific CD4+ and CD8+ #Tcell immunity that is not further enhanced by booster vaccination: science.org/doi/10.1126/sc…

A new study compares #SARSCoV2 vaccines in people, suggesting that boosters did not vastly improve T cell responses—which were already sufficiently robust—but did improve antibody reactions. Universität Tübingen yacine.maringer Peptide-based Immunotherapy 📄: scim.ag/pN

Check out the #article in our local #Newspaper Tagblatt Redaktion about our work on #TCELL responses in #COVID19 vaccinated donors. tagblatt.de/Nachrichten/T-…

„Santa Claus“ was in town! Check out how we celebrated the season with the appropriate costumes.

Das SPRIND, Federal Agency for Breakthrough Innovation-Tochterunternehmen BiconY Therapeutics GmbH übernimmt die Finanzierung der Weiterentwicklung von neuen Methoden zur Behandlung von soliden Tumoren mit bispezifischen Antikörpern sprind.org/de/projekte/bi…

🎅🏻 Celebrating our annual #NikolausParty on the 6th! 🎉 Polina Kaidun stole the show as the #MouseKing from #TheNutcracker. 💫 Gratitude to my colleagues for making it memorable and their outstanding work in #2023. Cheers to a fantastic #team! 🎄

Glad to share our latest paper in Science Translational Medicine on novel immunocytokines containing mutations to enable target-restricted activity, reducing systemic side effects and enhancing efficacy. Thanks to all contributors! science.org/doi/10.1126/sc…

Happy to announce that Jens Bauer from our lab together with Ashish Goyal and Joschka Hey were awarded the #WaltraudLewenzPreis 2023 DKFZ for their work on "DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts".

💫 Exciting news! Our B7H3xCD3 #bispecific #antibody CC-3 shows promise in fighting bone & soft tissue sarcomas. Congrats to Samuel Holzmayer & team! Melly M Visualizing and Targeting Cancer Stress #immunotherapy ➡️frontiersin.org/journals/immun…